These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24663101)

  • 21. Cyclophilin A potentiates TRIM5α inhibition of HIV-1 nuclear import without promoting TRIM5α binding to the viral capsid.
    Burse M; Shi J; Aiken C
    PLoS One; 2017; 12(8):e0182298. PubMed ID: 28767697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency.
    Schaller T; Ocwieja KE; Rasaiyaah J; Price AJ; Brady TL; Roth SL; Hué S; Fletcher AJ; Lee K; KewalRamani VN; Noursadeghi M; Jenner RG; James LC; Bushman FD; Towers GJ
    PLoS Pathog; 2011 Dec; 7(12):e1002439. PubMed ID: 22174692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue-specific restriction of cyclophilin A-independent HIV-1- and SIV-derived lentiviral vectors.
    Kahl CA; Cannon PM; Oldenburg J; Tarantal AF; Kohn DB
    Gene Ther; 2008 Aug; 15(15):1079-89. PubMed ID: 18385767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of cyclophilin A-dependent TRIM5 alpha restriction against HIV-1.
    Lin TY; Emerman M
    Virology; 2008 Sep; 379(2):335-41. PubMed ID: 18678385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclophilin A protects HIV-1 from restriction by human TRIM5α.
    Kim K; Dauphin A; Komurlu S; McCauley SM; Yurkovetskiy L; Carbone C; Diehl WE; Strambio-De-Castillia C; Campbell EM; Luban J
    Nat Microbiol; 2019 Dec; 4(12):2044-2051. PubMed ID: 31636416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell Type-Dependent Escape of Capsid Inhibitors by Simian Immunodeficiency Virus SIVcpz.
    Twizerimana AP; Scheck R; Becker D; Zhang Z; Wammers M; Avelar L; Pflieger M; Häussinger D; Kurz T; Gohlke H; Münk C
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32907979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CA Mutation N57A Has Distinct Strain-Specific HIV-1 Capsid Uncoating and Infectivity Phenotypes.
    Fischer DK; Saito A; Kline C; Cohen R; Watkins SC; Yamashita M; Ambrose Z
    J Virol; 2019 May; 93(9):. PubMed ID: 30814280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations in CypA Binding Region of HIV-1 Capsid Affect Capsid Stability and Viral Replication in Primary Macrophages.
    Setiawan LC; van Dort KA; Rits MA; Kootstra NA
    AIDS Res Hum Retroviruses; 2016 Apr; 32(4):390-8. PubMed ID: 26414211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficient transduction of simian cells by HIV-1-based lentiviral vectors that contain mutations in the capsid protein.
    Rits MA; van Dort KA; Münk C; Meijer AB; Kootstra NA
    Mol Ther; 2007 May; 15(5):930-7. PubMed ID: 17299408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of HIV-1 uncoating in human microglial cell lines.
    Ingram Z; Taylor M; Okland G; Martin R; Hulme AE
    Virol J; 2020 Mar; 17(1):31. PubMed ID: 32143686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SUN1 Regulates HIV-1 Nuclear Import in a Manner Dependent on the Interaction between the Viral Capsid and Cellular Cyclophilin A.
    Luo X; Yang W; Gao G
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29643244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclophilin A is an essential cofactor for hepatitis C virus infection and the principal mediator of cyclosporine resistance in vitro.
    Yang F; Robotham JM; Nelson HB; Irsigler A; Kenworthy R; Tang H
    J Virol; 2008 Jun; 82(11):5269-78. PubMed ID: 18385230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of capsid mutations that alter the rate of HIV-1 uncoating in infected cells.
    Hulme AE; Kelley Z; Okocha EA; Hope TJ
    J Virol; 2015 Jan; 89(1):643-51. PubMed ID: 25339776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors.
    Towers GJ; Hatziioannou T; Cowan S; Goff SP; Luban J; Bieniasz PD
    Nat Med; 2003 Sep; 9(9):1138-43. PubMed ID: 12897779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of dual inhibitors targeting both HIV-1 capsid and human cyclophilin A to inhibit the assembly and uncoating of the viral capsid.
    Li J; Tan Z; Tang S; Hewlett I; Pang R; He M; He S; Tian B; Chen K; Yang M
    Bioorg Med Chem; 2009 Apr; 17(8):3177-88. PubMed ID: 19328002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclophilin A is required for TRIM5{alpha}-mediated resistance to HIV-1 in Old World monkey cells.
    Berthoux L; Sebastian S; Sokolskaja E; Luban J
    Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14849-53. PubMed ID: 16203999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potent and reversible lentiviral vector restriction in murine induced pluripotent stem cells.
    Geis FK; Galla M; Hoffmann D; Kuehle J; Zychlinski D; Maetzig T; Schott JW; Schwarzer A; Goffinet C; Goff SP; Schambach A
    Retrovirology; 2017 May; 14(1):34. PubMed ID: 28569216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilization.
    Shi J; Zhou J; Shah VB; Aiken C; Whitby K
    J Virol; 2011 Jan; 85(1):542-9. PubMed ID: 20962083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclophilin A interacts with diverse lentiviral capsids.
    Lin TY; Emerman M
    Retrovirology; 2006 Oct; 3():70. PubMed ID: 17038183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The interferon-inducible MxB protein inhibits HIV-1 infection.
    Liu Z; Pan Q; Ding S; Qian J; Xu F; Zhou J; Cen S; Guo F; Liang C
    Cell Host Microbe; 2013 Oct; 14(4):398-410. PubMed ID: 24055605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.